Cargando…

Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study

Sodium‐glucose cotransporter 2 (SGLT2) inhibitors reduce the occurrence of cardiovascular and renal complications in patients with type 2 diabetes mellitus (T2DM) and represent guideline‐recommended therapy in this indication. However, precise mechanisms underlying the beneficial cardiovascular effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kario, Kazuomi, Okada, Kenta, Murata, Mitsunobu, Suzuki, Daisuke, Yamagiwa, Kayo, Abe, Yasuhisa, Usui, Isao, Tsuchiya, Norihiro, Iwashita, Chie, Harada, Noriko, Okawara, Yukie, Ishibashi, Shun, Hoshide, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Sglt2 Inhibition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590106/ https://www.ncbi.nlm.nih.gov/pubmed/32810338 http://dx.doi.org/10.1111/jch.13988

Ejemplares similares

Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA study
por: Okada, Kenta, et al.
Publicado: (2020)

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
por: Herrington, William G, et al.
Publicado: (2018)

Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2019)

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2019)

Sodium-glucose cotransporter inhibitors: beyond glycaemic control
por: Vergara, Ander, et al.
Publicado: (2019)

Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

How can sodium–glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron‐deficient? Implications for understanding iron homeostasis in heart failure
por: Packer, Milton
Publicado: (2022)

Dapagliflozin's effect on serum homocysteine in patients with hypertension complicated with insulin resistance
por: Yu, Xiaoqian, et al.
Publicado: (2023)

Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended
por: Kario, Kazuomi, et al.
Publicado: (2023)

Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice: The J-HOP Nocturnal Blood Pressure Study
por: Kario, Kazuomi, et al.
Publicado: (2019)

Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
por: Connelly, Kim A., et al.
Publicado: (2019)

SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
por: Lim, Ven G., et al.
Publicado: (2019)

Rationale, study design, and implementation of the ACS1 study: effect of azilsartan on circadian and sleep blood pressure as compared with amlodipine
por: Kario, Kazuomi, et al.
Publicado: (2014)

Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
por: Nagai, Michiaki, et al.
Publicado: (2010)

Self‐measured worksite blood pressure and its association with organ damage in working adults: Japan Morning Surge Home Blood Pressure (J‐HOP) worksite study
por: Tomitani, Naoko, et al.
Publicado: (2020)

Association of lower nighttime diastolic blood pressure and hypoxia with silent myocardial injury: The Japan Morning Surge‐Home Blood Pressure study
por: Kubota, Kana, et al.
Publicado: (2020)

Digital Hypertension 2023: Concept, hypothesis, and new technology
por: Kario, Kazuomi, et al.
Publicado: (2022)

Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease‐Induced Resistant Hypertension: Further Considerations for 24‐Hour Blood Pressure Profiles
por: Narita, Keisuke, et al.
Publicado: (2022)

Changes in Blood Pressure Reactivity Against Physical Activity Evaluated by Multisensor-ABPM in Heart Failure Patients
por: Narita, Keisuke, et al.
Publicado: (2022)

Simultaneous self‐monitoring comparison of a supine algorithm‐equipped wrist nocturnal home blood pressure monitoring device with an upper arm device
por: Kario, Kazuomi, et al.
Publicado: (2021)

The Combination of Non-dipper Heart Rate and High Brain Natriuretic Peptide Predicts Cardiovascular Events: The Japan Morning Surge-Home Blood Pressure (J-HOP) Study
por: Ogoyama, Yukako, et al.
Publicado: (2020)

Different age‐related impacts of lean and obesity on cardiovascular prognosis in Japanese patients with cardiovascular risks: The J‐HOP (Japan Morning Surge‐Home Blood Pressure) Study
por: Toriumi, Shinichi, et al.
Publicado: (2021)

Atrial fibrillation is associated with cardiovascular events in obese Japanese with one or more cardiovascular risk factors: The Japan Morning Surge Home Blood Pressure (J‐HOP) Study
por: Watanabe, Hiroaki, et al.
Publicado: (2021)

Automatically assessed P‐wave predicts cardiac events independently of left atrial enlargement in patients with cardiovascular risks: The Japan Morning Surge‐Home Blood Pressure Study
por: Yokota, Ayako, et al.
Publicado: (2020)

Growth Differentiation Factor 15 Predicts Cancer Death in Patients With Cardiovascular Risk Factors: The J-HOP Study
por: Negishi, Keita, et al.
Publicado: (2021)

Impact of home blood pressure variability on cardiovascular outcome in patients with arterial stiffness: Results of the J‐HOP study
por: Ishiyama, Yusuke, et al.
Publicado: (2021)

Seasonal Variation of Home Blood Pressure and Its Association With Target Organ Damage: The J-HOP Study (Japan Morning Surge-Home Blood Pressure)
por: Narita, Keisuke, et al.
Publicado: (2020)

Comparative effects of valsartan plus cilnidipine or hydrochlorothiazide on nocturnal home blood pressure
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
por: Negishi, Keita, et al.
Publicado: (2021)

Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
por: Majewski, Colleen, et al.
Publicado: (2015)

Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy
por: Rosenstock, Julio, et al.
Publicado: (2015)

SGLT2 Inhibitors: The Latest “New Kids on the Block”!
por: Cefalu, William T., et al.
Publicado: (2015)

Short telomere length is associated with renal impairment in Japanese subjects with cardiovascular risk
por: Eguchi, Kazuo, et al.
Publicado: (2017)

Quantitative evaluation of white matter hyperintensities in patients with heart failure using an innovative magnetic resonance image analysis method: Association with disrupted circadian blood pressure variation
por: Komori, Takahiro, et al.
Publicado: (2021)

Differences in ambulatory blood pressure profiles between Japanese and Thai patients with hypertension /suspected hypertension
por: Tomitani, Naoko, et al.
Publicado: (2020)

Association of Night‐to‐Night Adherence of Continuous Positive Airway Pressure With Day‐to‐Day Morning Home Blood Pressure and Its Seasonal Variation in Obstructive Sleep Apnea
por: Hoshide, Satoshi, et al.
Publicado: (2022)

Assessment of a new algorithm to detect atrial fibrillation in home blood pressure monitoring device among healthy adults and patients with atrial fibrillation
por: Watanabe, Tomonori, et al.
Publicado: (2021)

Unusual Case of Adult-Onset Congestive Heart Failure Due to Long-Lasting Cardiac Volume Overload Caused by Spinal Epidural Arteriovenous Fistulas
por: Oba, Yusuke, et al.
Publicado: (2023)

Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study
por: Bouchi, Ryotaro, et al.
Publicado: (2017)

Medical Telemonitoring for the Management of Hypertension in Older Patients in Japan
por: Fujiwara, Takeshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i8lpat2ngu8feenv0d22itkk0g